Skip to product information
1 of 1
HPLC-Verified > 99%

Tirzepatide

Tirzepatide

Lyophilized Peptide • Research Grade
Regular price $139.00 USD
Regular price Sale price $139.00 USD
Sale Sold out
Volume
Quantity

Certificate of Analysis

Third Party Tested

TLDR

TL;DR:

A dual GLP-1R/GIPR agonist used to investigate incretin-receptor co-activation, insulinotropic signaling, and energy-homeostasis pathways.

Description

Product Description
Tirzepatide is a dual GLP-1R/GIPR agonist supplied as ≥98% pure lyophilized powder for incretin-receptor co-activation research.

Key Research Mechanism
Simultaneous GLP-1 and GIP receptor engagement is used to study insulinotropic signaling, β-cell models, and energy-homeostasis pathways.

Primary Research Areas

  • Dual incretin-receptor pharmacology
  • Insulin-secretion assays
  • Metabolic GPCR signaling

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.

Shipping & Returns

Orders placed by 3PM will ship same day. All orders placed after 3PM will ship next business day.

Injectables are Non-returnable items
Certain types of items cannot be returned, like perishable goods (such as food, flowers, or plants), custom products (such as special orders or personalized items), and personal care goods (such as beauty products, supplements, and injectables). We also do not accept returns for hazardous materials, flammable liquids, or gases.

Please get in touch if you have questions or concerns about the quality of your specific item and we will work on resolution.

View full details

Certificate of Analysis

Third Party Tested

Molecular Profile

A dual GLP-1R/GIPR agonist used to investigate incretin-receptor co-activation, insulinotropic signaling, and energy-homeostasis pathways.

Compound Tirzepatide
Batch # GLS250510-LC1091806
Formula C225H348N48O68
Mol Wt 4813 g/mol
CAS 2023788-19-2
Latest ISO 17025 8× Testing

99.63%

Purity
VariantTirzepatide
COA ##11577
Labeled50mg
Validation KeyAXISBIOTECH
Tested12/15/25
Full QC Panel - 8× tested
Purity (HPLC) - 99.63%
Net Peptide Content - 50mg
Identity (HPLC) - Tirzepatide
Fentanyl Screen - Not Detected
HPLC Conformity mean - >98%
ISO/IEC 17025 Accredited
Storage Requirements

Stability Information

Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder) −20°C long-term
2–8°C
Reconstituted Recommended condition
Light protection Store away from light

Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.

Certificate of Analysis

Precision Synthesis

Developed in collaboration with leading US-based scientific facilities to push the boundaries of biochemical research.

Explore Research Blog

Safety & Regulatory Compliance Warning

These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.